Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision history shows addition of v3.3.2 and removal of v3.2.0 on the Study Record Versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removal of a site-wide government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T07:25:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status, Study Design, Outcome Measures, and Adverse Events across multiple versions, with notes on Quality Control status. There are also updates to Contacts/Locations within the record.
    Difference
    0.1%
    Check dated 2025-11-03T21:25:54.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-06T06:57:41.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:35:29.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2 (replacing v3.0.1). The 'Back to Top' element was removed, indicating a minor UI cleanup with no major content changes.
    Difference
    0.7%
    Check dated 2025-09-14T21:42:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.